Apoptosis in the liver of male db/db mice during the development of obesity and type 2 diabetes

Obesity and diabetes mellitus are known to lead to the development of metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). The mechanisms of programmed cell death are actively involved in maintaining cellular homeostasis along development of NAFLD. Proteins of the BCL-2 family are key regulators of physiological and pathological apoptosis. Homozygous males of BKS.Cg-Dock7^mLepr^db/+/+/J mice (db/db mice) are characterized by progressive obesity and the development of type 2 diabetes mellitus (DM2) with severe hyperglycemia at 4–8 weeks and organ lesions at 8–10 weeks of age. The aim of this research was to study the expression of molecular cell regulators of apoptosis in liver cells of db/db mice males at different stages of obesity and diabetes development (at the age of 10 and 18 weeks). Immunohistochemical analysis (using the indirect avidin-biotin peroxidase method) and morphometric evaluation of the expression of the antiapoptotic protein Bcl-2 and the proapoptotic protein Bad in liver cells of studied animals at different stages of obesity and DM2 were carried out. An excess of the value of the Bcl-2 protein staining area over the Bad protein staining area was revealed in the liver of 10-week-old animals. The Bcl-2/Bad expression area ratio in 10-week-old animals was twice as high as in 18-week-old animals, which indicates the presence of conditions for blocking apoptosis in the liver of younger db/db mice. At the 18th week of life, db/db mice displayed an almost threefold increase in the expression area of the Bad protein against the background of an unchanged expression of the Bcl-2 protein. The decrease in the Bcl-2/Bad staining area ratio in 18-week-old animals was due to the increase in the Bad expression area, which indicates the absence of antiapoptotic cell protection and creates conditions for activation of the mitochondrial pathway of apoptosis in the liver of male db/db mice with pronounced signs of obesity and DM2.

db/db mice, obesity, type 2 diabetes mellitus (DM2), liver, endothelial cells, hepatocytes, Bcl-2, Bad

1. Begriche K., Massart J., Robin M.A., Borgne-Sanchez A., Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J. Hepatol. 2011;54(4):773-794. DOI 10.1016/j.jhep.2010.11.006.

2. Chevalier R.L., Smith C.D., Wolstenholme J., Krajewski S., Reed J.C. Chronic ureteral obstruction in the rat suppresses renal tubular Bcl-2 and stimulates apoptosis. Exp. Nephrol. 2000;8(2):115-122. DOI 10.1159/000020657.

3. Dewanjee S., Dua T.K., Khanra R., Das S., Barma S., Joardar S., Bhattacharjee N., Zia-Ul-Haq M., Jaafar H.Z. Water spinach, Ipomoea aquatic (Convolvulaceae), ameliorates lead toxicity by inhibiting oxidative stress and apoptosis. PLoS One. 2015;10(10):e0139831. DOI 10.1371/journal.pone.0139831.

4. Eckert A., Keil U., Kressmann S., Schindowski K., Leutner S., Leutz S., Müller W.E. Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry. 2003; 36(Suppl. 1):S15-S23. DOI 10.1055/с-2003-40449.

5. Flurkey K., Currer J.M., Harrison D.E. Mouse models in aging research. In: Fox J.G., Barthold S.W., Davisson M.T., Newcomer C.E., Quimby F.W., Smith A.L. (Eds.). The Mouse in Biomedical Research. 2nd Edition. New York: Elsevier, 2006;3:637-672.

6. Hu J., Srivastava K., Wieland M., Runge A., Mogler C., Besemfelder E., Terhardt D., Vogel M.J., Cao L., Korn C., Bartels S., Thomas M., Augustin H.G. Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat. Science. 2014;343(6169):416-419. DOI 10.1126/science.1244880.

7. Hutchins N.A., Chung C.S., Borgerding J.N., Ayala C.A., Ayala A. Kupffer cells protect liver sinusoidal endothelial cells from Fasdependent apoptosis in sepsis by down-regulating gp130. Am. J. Pathol. 2013;182(3):742-754. DOI 10.1016/j.ajpath.2012.11.023.

8. Kolesnikov S.I., Semenyuk A.V., Grachev S.V. Toxicant Action Imprinting in Embryogenesis. Moscow, 1999. (in Russian)

9. Michurina S.V., Ishchenko I.Yu., Arkhipov S.A., Klimontov V.V., Rachkovskaya L.N., Konenkov V.I., Zavyalov E.L. Effects of melatonin, aluminum oxide, and polymethylsiloxane complex on the expression of LYVE-1 in the liver of mice with obesity and type 2 diabetes mellitus. Bulletin of Experimental Biology and Medicine. 2016a;162(2):269-272. DOI 10.1007/s10517-016-3592-y.

10. Michurina S.V., Ishenko I.J., Klimontov V.V., Archipov S.A., Myakina N.E., Cherepanova M.A., Zavjalov E.L., Koncevaya G.V., Konenkov V.I. Linagliptin alleviated fatty liver disease in diabetic db/db mice. World J. Diabetes. 2016b;7(19):534-546. DOI 10.4239/wjd.v7.i19.534.

11. Mushkambarov N.N., Kuznetsov S.L. Molecular Biology. Moscow, 2007. (in Russian)

12. Paltsev M.A. Molecular medicine and progress in basic sciences. Vestnik Rossiyskoy Akademii Nauk = Herald of the Russian Academy of Sciences. 2002;72(1):13-21. (in Russian)

13. Schuppan D., Schattenberg J.M. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J. Gastroenterol. Hepatol. 2013;28(Suppl. 1):68-76. DOI 10.1111/jgh.12212.

14. Shimizu M., Yasuda Y., Sakai H., Kubota M., Terakura D., Baba A., Ohno T., Kochi T., Tsurumi H., Tanaka T., Moriwaki H. Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice. BMC Cancer. 2011;11:281. DOI 10.1186/1471-2407-11-281.

15. Sun D., Li S., Wu H., Zhang M., Zhang X., Wei L., Qin X., Gao E. Oncostatin M (OSM) protects against cardiac ischaemia/reperfusion injury in diabetic mice by regulating apoptosis, mitochondrial biogenesis and insulin sensitivity. J. Cell. Mol. Med. 2015;19(6):1296- 1307. DOI 10.1111/jcmm.12501.

16. Trak-Smayra V., Paradis V., Massart J., Nasser S., Jebara V., Fromenty B. Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. Int. J. Exp. Pathol. 2011; 92(6):413-421. DOI 10.1111/j.1365-2613.2011.00793.x.